Literature DB >> 19073161

Characterization of (14)C-acetate uptake in cultured rat astrocytes.

Rie Hosoi1, Yasuyo Matsuyama, Shin-ichiro Hirose, Yutaka Koyama, Toshio Matsuda, Antony Gee, Osamu Inoue.   

Abstract

To investigate the regulation mechanism of (14)C-acetate uptake in astrocytes, uptake experiments with cultured rat astrocytes were performed. In this study, we used a relatively low concentration (0.0185 mM) of (14)C-acetate. The uptake was dependent on pH and acetate concentration, and saturated by 10 mM acetate. Furthermore, the selective inhibition by p-(chloromercuri) benzenesulfonic acid (pCMBS) but not by alpha-cyano-3-hydroxycinnamate (CHC) showed that the monocarboxylate transporter-1 (MCT-1)-mediated transport system is essentially important in cultured rat astrocytes. A significant reduction (more than 30%) in (14)C-acetate uptake was observed with 0.5 mM fluorocitrate treatment, which indicated (14)C-acetate uptake in this study might reflect not only the transport process, but also the metabolic process. Glutamate significantly increased (14)C-acetate uptake. An increase in extracellular potassium concentration had no effect on (14)C-acetate uptake. The Ca(2+) ionophore A23187 caused a 40% reduction, and ouabain (inhibitor of Na(+)-K(+)-ATPase) and monensin (Na(+) ionophore) significantly decreased (14)C-acetate uptake by astrocytes. The combined use of ouabain and monensin caused significantly greater decreases than the addition of either chemical alone. These results suggest that glutamate stimulation and changes in Ca(2+) and Na(+) concentrations might have important roles in regulation of (14)C-acetate uptake in cultured rat astrocytes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19073161     DOI: 10.1016/j.brainres.2008.11.068

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

Review 1.  Labeled acetate as a marker of astrocytic metabolism.

Authors:  Matthias T Wyss; Pierre J Magistretti; Alfred Buck; Bruno Weber
Journal:  J Cereb Blood Flow Metab       Date:  2011-06-08       Impact factor: 6.200

2.  Modulation of inflammatory cytokines and mitogen-activated protein kinases by acetate in primary astrocytes.

Authors:  Mahmoud L Soliman; Colin K Combs; Thad A Rosenberger
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-12       Impact factor: 4.147

3.  Altered expression of brain monocarboxylate transporter 1 in models of temporal lobe epilepsy.

Authors:  Fredrik Lauritzen; Edgar L Perez; Eric R Melillo; Jung-Min Roh; Hitten P Zaveri; Tih-Shih W Lee; Yue Wang; Linda H Bergersen; Tore Eid
Journal:  Neurobiol Dis       Date:  2011-08-10       Impact factor: 5.996

4.  Neuronal glucose metabolism is impaired while astrocytic TCA cycling is unaffected at symptomatic stages in the hSOD1G93A mouse model of amyotrophic lateral sclerosis.

Authors:  Tesfaye W Tefera; Karin Borges
Journal:  J Cereb Blood Flow Metab       Date:  2018-03-19       Impact factor: 6.200

5.  Evaluation of 2-[¹⁸F]fluoroacetate kinetics in rodent models of cerebral hypoxia-ischemia.

Authors:  Yu Ouyang; Jeff N Tinianow; Simon R Cherry; Jan Marik
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-12       Impact factor: 6.200

6.  Nanostructured lipid carriers for percutaneous administration of alkaloids isolated from Aconitum sinomontanum.

Authors:  Teng Guo; Yongtai Zhang; Jihui Zhao; Chunyun Zhu; Nianping Feng
Journal:  J Nanobiotechnology       Date:  2015-07-10       Impact factor: 10.435

7.  11C-acetate PET imaging in patients with multiple sclerosis.

Authors:  Kazushiro Takata; Hiroki Kato; Eku Shimosegawa; Tatsusada Okuno; Toru Koda; Tomoyuki Sugimoto; Hideki Mochizuki; Jun Hatazawa; Yuji Nakatsuji
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

8.  Hyperoxia induces glutamine-fuelled anaplerosis in retinal Müller cells.

Authors:  Charandeep Singh; Vincent Tran; Leah McCollum; Youstina Bolok; Kristin Allan; Alex Yuan; George Hoppe; Henri Brunengraber; Jonathan E Sears
Journal:  Nat Commun       Date:  2020-03-09       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.